Betteromics, a Redwood City, CA-based provider of a clinical-grade compliant Software-as-a-Service platform, raised $20 million in Series A funding.
The round was led by Sofinnova Partners and Triatomic Capital, with participation from SHAKTI.
Founded in 1972, Sofinnova Partners is a venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, The firm prefers to invest in seed to later-stage companies.
Founded in 2022, Triatomic Capital is a venture capital firm based in Incline Village, Nevada. The firm seeks to invest in healthtech, deeptech, biotechnology, medtech, energy and artificial intelligence sectors.
Betteromics Use of Funds
The company intends to use the funds to expand the team, and scale marketing and sales efforts to life science companies, ranging from startups to the largest enterprises.
Led by Angela Lai, Founder and CEO, Chetan Patel, Chief Technology Officer, and Jack Menzel, Chief Product Officer, Betteromics is an end-to-end multi-omics data platform. It aims to enable scientists, researchers, and clinicians to understand and gain insights from massive amounts of data using advanced computation and AI techniques. The Omics AI Cloud streamlines the creation of knowledge graphs, integrating and connecting data with emerging standards and ontologies from disparate silos. The platform is tailored to a range of users, from diagnostic and therapeutic product developers to biotech manufacturers needing real-time quality monitoring.
Designed with compliance at its core, the platform is certified to ISO 9001 and ISO 27001, SOC2 Type II, and HITRUST i1.
Company: Betteromics, Inc.
Round: Series A
Funding Month: October 2023
Lead Investors: Sofinnova Partners and Triatomic Capital
Additional Investors: SHAKTI
Company Website: https://www.betteromics.com/
Software Category: Multi-Omics Data Platform